| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
The pathogeneses of toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS), both severe blistering diseases usually associated with drug intake, are not fully elucidated. Histologically, both TEN and SJS are characterized by extensive keratinocyte apoptosis. Previous studies have shown that keratinocyte apoptosis in TEN and SJS was induced by a suicidal interaction between Fas and Fas ligand (FasL), which are both expressed by keratinocytes. However, our preliminary examinations demonstrated that FasL is hardly detected on keratinocytes. We hypothesized that soluble FasL (sFasL) is secreted by peripheral blood mononuclear cells (PBMCs), and this interacts with the Fas expressed on keratinocytes in TEN and SJS. To justify this hypothesis, we investigated whether sFasL secreted by PBMCs could induce the keratinocyte apoptosis in TEN and SJS. Enzyme-linked immunosorbent assay analysis demonstrated that there was no significant sFasL increase in any samples of healthy controls (<40 pg/ml, n = 14) and patients with an ordinary erythema multiforme-type drug eruption (41.5 ± 3.1 pg/ml, n = 14), whereas high concentrations are detected in all samples of TEN and SJS patients (TEN: 131.5 ± 57.4 pg/ml, n = 8; SJS: 119.1 ± 41.0 pg/ml, n = 14) (P < 0.0001). In vitro analysis using cultured keratinocytes revealed that the sera of TEN and SJS patients induced abundant keratinocyte apoptosis compared to erythema multiforme-type drug eruption sera. Furthermore, on stimulation with the causal drug, PBMCs obtained from TEN and SJS patients secreted high levels of sFasL. Taken together, these results indicate that sFasL secreted by PBMCs, not keratinocytes, plays a crucial role in the apoptosis and pathomechanism of TEN and SJS, and that the serum sFasL level may be a good indicator for the early diagnosis of TEN and SJS.
This article has been cited by other articles:
 |
|
 |
|
  A. M. Wani, W. M. Hussain, M. I. Fatani, K. S. Ali, A. M. Khoujah, M. Akhtar, G. A. A. Maimani, S. H. Raja, A. Basraheel, and K. Fareed Don't live in a town where there are no doctors: toxic epidermal necrolysis initially misdiagnosed as oral thrush BMJ Case Reports, December 30, 2009; 2009(dec30_1): bcr1020092392 - bcr1020092392. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Abe, N. Yoshioka, J. Murata, Y. Fujita, and H. Shimizu Granulysin as a Marker for Early Diagnosis of the Stevens-Johnson Syndrome Ann Intern Med, October 6, 2009; 151(7): 514 - 515. [Full Text] [PDF]
|
|
|
|
 |
|
 M Ueta, C Sotozono, T Inatomi, K Kojima, J Hamuro, and S Kinoshita Association of Fas Ligand gene polymorphism with Stevens-Johnson syndrome Br J Ophthalmol, July 1, 2008; 92(7): 989 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Mukasa and N Craven Management of toxic epidermal necrolysis and related syndromes Postgrad. Med. J., February 1, 2008; 84(988): 60 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Eidsmo, C. Fluur, B. Rethi, S. Eriksson Ygberg, N. Ruffin, A. De Milito, H. Akuffo, and F. Chiodi FasL and TRAIL Induce Epidermal Apoptosis and Skin Ulceration Upon Exposure to Leishmania major Am. J. Pathol., January 1, 2007; 170(1): 227 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. P. K. Ang, T. Nakamura, T. Inatomi, C. Sotozono, N. Koizumi, N. Yokoi, and S. Kinoshita Autologous serum-derived cultivated oral epithelial transplants for severe ocular surface disease. Arch Ophthalmol, November 1, 2006; 124(11): 1543 - 1551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Quinn, K. Brown, B. K. Bonish, J. Curry, K. B. Gordon, J. Sinacore, R. Gamelli, and B. J. Nickoloff Uncovering Histologic Criteria With Prognostic Significance in Toxic Epidermal Necrolysis Arch Dermatol, June 1, 2005; 141(6): 683 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Eidsmo, S. Nylen, A. Khamesipour, M.-A. Hedblad, F. Chiodi, and H. Akuffo The Contribution of the Fas/FasL Apoptotic Pathway in Ulcer Formation during Leishmania major-Induced Cutaneous Leishmaniasis Am. J. Pathol., April 1, 2005; 166(4): 1099 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-I. Hung, W.-H. Chung, L.-B. Liou, C.-C. Chu, M. Lin, H.-P. Huang, Y.-L. Lin, J.-L. Lan, L.-C. Yang, H.-S. Hong, et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol PNAS, March 15, 2005; 102(11): 4134 - 4139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-i. Yamagishi, R. Abe, Y. Inagaki, K. Nakamura, H. Sugawara, D. Inokuma, H. Nakamura, T. Shimizu, M. Takeuchi, A. Yoshimura, et al. Minodronate, a Newly Developed Nitrogen-Containing Bisphosphonate, Suppresses Melanoma Growth and Improves Survival in Nude Mice by Blocking Vascular Endothelial Growth Factor Signaling Am. J. Pathol., December 1, 2004; 165(6): 1865 - 1874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Takemura, K. Fukuo, O. Yasuda, T. Inoue, N. Inomata, T. Yokoi, H. Kawamoto, T. Suhara, and T. Ogihara Fas Signaling Induces Akt Activation and Upregulation of Endothelial Nitric Oxide Synthase Expression Hypertension, April 1, 2004; 43(4): 880 - 884. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
